Green Thumb Industries (GTBIF) Cash from Operations (QoQ) (2019 - 2026)
Green Thumb Industries (GTBIF) Cash from Operations (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Green Thumb Industries | 1.66 Bn | 1.37 Bn | 137.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -61.73% |
| Mar 31, 2026 | -15.91% |
| Dec 31, 2025 | 21.62% |
| Sep 30, 2025 | 31.31% |
| Jun 30, 2025 | -23.95% |
| Mar 31, 2025 | 71.26% |
| Dec 31, 2024 | -9.09% |
| Sep 30, 2024 | 136.57% |
| Jun 30, 2024 | -76.02% |
| Mar 31, 2024 | 18.18% |
| Dec 31, 2023 | 16.85% |
| Sep 30, 2023 | 232.17% |
| Jun 30, 2023 | -75.48% |
| Mar 31, 2023 | 6.21% |
| Dec 31, 2022 | 45.62% |
| Sep 30, 2022 | 412.42% |
| Jun 30, 2022 | -127.92% |
| Mar 31, 2022 | 12.37% |
| Dec 31, 2021 | 42.97% |
| Sep 30, 2021 | 298.91% |